Nausea , vomiting , and diarrhea were more common in the apremilast group ( with @ , @ , and @ incidents , respectively , among @ patients ) than in the placebo group ( with @ , @ , and @ incidents , respectively , among @ patients ) , findings that were similar to those in previous studies of apremilast .